ArticleFrontiers in pharmacology2023

Astragaloside IV alleviates 1-deoxysphinganine-induced mitochondrial dysfunction during the progression of chronic kidney disease through p62-Nrf2 antioxidant pathway.

Ting Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.